Development of a safe live genetically attenuated blood stage malaria vaccine [ 2013 - ]

Research Grant

Researchers: Dr Krystal Evans (Principal investigator) ,  Prof Daniel Schofield (Principal investigator) ,  Prof Alan Cowman ,  Prof James McCarthy

Brief description Malaria presents an enormous global health problem, and also has a significant impact on social and economic development in countries where the disease is endemic. Our project will produce a live genetically-modified vaccine against Plasmodium falciparum, the parasite that causes the form of malaria mostly deadly to humans. Our development plan will include the first ever clinical trials of a malaria vaccine of this kind and will look at vaccine safety and effectiveness.

Funding Amount $822,191.00

Funding Scheme Development Grants

Notes Development Grant